BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34047629)

  • 21. Synthesis of poly(alkyl cyanoacrylate)-based colloidal nanomedicines.
    Nicolas J; Couvreur P
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(1):111-127. PubMed ID: 20049783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted Delivery of Cabazitaxel by Conjugation to Albumin-PEG-folate Nanoparticles Using a Cysteine-acrylate Linker and Simple Synthesis Conditions.
    Khoeeniha MK; Esfandyari-Manesh M; Behrouz H; Amini M; Varnamkhasti BS; Atyabi F; Dinarvand R
    Curr Drug Deliv; 2017; 14(8):1120-1129. PubMed ID: 27875950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small variations in nanoparticle structure dictate differential cellular stress responses and mode of cell death.
    Szwed M; Sønstevold T; Øverbye A; Engedal N; Grallert B; Mørch Ý; Sulheim E; Iversen TG; Skotland T; Sandvig K; Torgersen ML
    Nanotoxicology; 2019 Aug; 13(6):761-782. PubMed ID: 30760074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced biocompatibility and wound healing properties of biodegradable polymer-modified allyl 2-cyanoacrylate tissue adhesive.
    Lee YJ; Son HS; Jung GB; Kim JH; Choi S; Lee GJ; Park HK
    Mater Sci Eng C Mater Biol Appl; 2015 Jun; 51():43-50. PubMed ID: 25842106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality by design fostered fabrication of cabazitaxel loaded pH-responsive Improved nanotherapeutics against prostate cancer.
    Shah S; Famta P; Kumar R; Sharma A; Vambhurkar G; Pandey G; Singh G; Kumar P; Mehra A; Mourya A; Srinivasarao DA; Shinde A; Prasad SB; Khatri DK; Madan J; Srivastava S
    Colloids Surf B Biointerfaces; 2024 Feb; 234():113732. PubMed ID: 38181691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing entrapment of peptides within poly(alkyl cyanoacrylate) nanoparticles prepared from water-in-oil microemulsions by copolymerization.
    Liang M; Davies NM; Toth I
    Int J Pharm; 2008 Oct; 362(1-2):141-6. PubMed ID: 18598746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of glioblastoma with poly(isohexyl cyanoacrylate) nanoparticles.
    Wohlfart S; Khalansky AS; Bernreuther C; Michaelis M; Cinatl J; Glatzel M; Kreuter J
    Int J Pharm; 2011 Aug; 415(1-2):244-51. PubMed ID: 21641983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: Do nanocarrier properties have a role?
    Ostacolo L; Marra M; Ungaro F; Zappavigna S; Maglio G; Quaglia F; Abbruzzese A; Caraglia M
    J Control Release; 2010 Dec; 148(2):255-63. PubMed ID: 20816710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo evaluation of 10-hydroxycamptothecin-loaded poly (n-butyl cyanoacrylate) nanoparticles prepared by miniemulsion polymerization.
    Jin X; Asghar S; Zhu X; Chen Z; Tian C; Yin L; Ping Q; Xiao Y
    Colloids Surf B Biointerfaces; 2018 Feb; 162():25-34. PubMed ID: 29145001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.
    Jin X; Huang A; Ping Q; Cao F; Su Z
    Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epirubicin loading in poly(butyl cyanoacrylate) nanoparticles manifests via altered intracellular localization and cellular response in cervical carcinoma (HeLa) cells.
    Evangelatov A; Skrobanska R; Mladenov N; Petkova M; Yordanov G; Pankov R
    Drug Deliv; 2016 Sep; 23(7):2235-2244. PubMed ID: 25268149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of cabazitaxel-resistant mechanism in human castration-resistant prostate cancer.
    Hongo H; Kosaka T; Oya M
    Cancer Sci; 2018 Sep; 109(9):2937-2945. PubMed ID: 29989268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interlaboratory evaluation of a digital holographic microscopy-based assay for label-free in vitro cytotoxicity testing of polymeric nanocarriers.
    Marzi A; Eder KM; Barroso Á; Wågbø AM; Mørch Ý; Hatletveit AR; Visnes T; Schmid RB; Klinkenberg G; Kemper B; Schnekenburger J
    Drug Deliv Transl Res; 2022 Sep; 12(9):2207-2224. PubMed ID: 35799027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Standardization of an in vitro assay matrix to assess cytotoxicity of organic nanocarriers: a pilot interlaboratory comparison.
    Eder KM; Marzi A; Wågbø AM; Vermeulen JP; de la Fonteyne-Blankestijn LJJ; Rösslein M; Ossig R; Klinkenberg G; Vandebriel RJ; Schnekenburger J
    Drug Deliv Transl Res; 2022 Sep; 12(9):2187-2206. PubMed ID: 35794354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding instability and rupture of poly(alkyl-2-cyanoacrylate) capsules.
    Wischke C; Weigel J; Neffe AT; Lendlein A
    Int J Artif Organs; 2011 Feb; 34(2):243-8. PubMed ID: 21374580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-assembled Micelle Loading Cabazitaxel for therapy of Lung Cancer.
    Zhuang B; Du L; Xu H; Xu X; Wang C; Fan Y; Cong M; Yin J; Li H; Guan H
    Int J Pharm; 2016 Feb; 499(1-2):146-155. PubMed ID: 26762884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer's disease.
    Le Droumaguet B; Nicolas J; Brambilla D; Mura S; Maksimenko A; De Kimpe L; Salvati E; Zona C; Airoldi C; Canovi M; Gobbi M; Magali N; La Ferla B; Nicotra F; Scheper W; Flores O; Masserini M; Andrieux K; Couvreur P
    ACS Nano; 2012 Jul; 6(7):5866-79. PubMed ID: 22725248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances.
    Minnema J; Borgos SEF; Liptrott N; Vandebriel R; Delmaar C
    Drug Deliv Transl Res; 2022 Sep; 12(9):2132-2144. PubMed ID: 35551616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles.
    Duan J; Mansour HM; Zhang Y; Deng X; Chen Y; Wang J; Pan Y; Zhao J
    Int J Pharm; 2012 Apr; 426(1-2):193-201. PubMed ID: 22274587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer.
    Sekino Y; Han X; Kawaguchi T; Babasaki T; Goto K; Inoue S; Hayashi T; Teishima J; Shiota M; Yasui W; Matsubara A
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.